Author: News Room

Dublin, July 31, 2024 (GLOBE NEWSWIRE) — The “Gene Therapy – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.The global market for Gene Therapy is estimated at US$1.4 Billion in 2023 and is projected to reach US$6.0 Billion by 2030, growing at a CAGR of 23.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The growth in the gene therapy market is driven by several factors, including significant advancements in genetic research and biotechnological techniques. The increasing prevalence of genetic disorders and…

Dublin, July 31, 2024 (GLOBE NEWSWIRE) — The “Denim Jeans – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.The global market for Denim Jeans is estimated at US$74.0 Million in 2023 and is projected to reach US$114.6 Million by 2030, growing at a CAGR of 6.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The growth in the denim jeans market is driven by several factors. The enduring popularity of denim as a fashion statement and its versatility in styling contribute to…

SAN JOSE, Calif., July 31, 2024 (GLOBE NEWSWIRE) — Cavli Wireless, one of the first truly ‘IoT-ready’ cellular module manufacturers, proudly unveiled the new C11QM LTE Cat 1 IoT module. This latest addition to the flagship C-Series line leverages advanced LTE Cat 1 technology and the inbuilt GNSS tracking to deliver seamless global connectivity and tracking solutions. Designed to meet the diverse needs of modern IoT applications, the C11QM sets a new standard for efficiency and versatility in the industry. Cavli Wireless unveils the C11QM, a game-changing IoT module set to transform the connected device landscape. This compact powerhouse seamlessly…

Dublin, July 31, 2024 (GLOBE NEWSWIRE) — The “Global Embedded Finance Market Size, Share, Growth Analysis, By Type (Embedded Payments, Embedded Lending, Embedded Insurance, Embedded Wealth Management), Business Model, Industry (Retail & ECommerce, Healthcare) – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.The embedded finance market is estimated at USD 112.6 billion in 2024 and is projected to reach USD 237.4 billion by 2029, at a Compound Annual Growth Rate (CAGR) of 16.1%. Embedded finance improves access to financial products by including them in non-financial environments. They also enable organizations to provide secure monetary exchanges as products or…

Dublin, July 31, 2024 (GLOBE NEWSWIRE) — The “Global Mental Health Screening Market Size, Share & Trends Analysis Report by Component (Hardware, Software), Application (Cognitive, Behavioral), Demography, Solution Type, Region, and Segment Forecasts, 2024-2030” report has been added to ResearchAndMarkets.com’s offering.The global mental health screening market size is expected to reach USD 4.17 billion by 2030 and is projected to grow at a CAGR of 10.1% from 2024 to 2030 The rising prevalence of mental health disorders is increasing globally, thereby fostering market growth. According to the Household Pulse Survey conducted by the U.S. Census Bureau, 32.3% of adults reported…

LAS VEGAS, July 31, 2024 (GLOBE NEWSWIRE) — Cure 4 The Kids Foundation (C4K) announced it has completed Nevada’s first successful infusion of Hemgenix®, a gene therapy option for adult patients with hemophilia B — a genetic bleeding disorder in which people do not produce a protein needed to create blood clots. Depending on severity, a hemophilia B patient can require multiple infusions of factor IX on a weekly basis to prevent a bleed. However, after the one-time Hemgenix® infusion, the gene therapy is expected to enable the individual’s body to produce their own Factor IX, eliminating weekly infusions. Under…

ADELAIDE, Australia and WAKE FOREST, N.C., July 31, 2024 (GLOBE NEWSWIRE) — Avance Clinical, an award-winning, mid-sized full-service global Contract Research Organization (CRO) for biotech companies, is pleased to announce the appointment of Jeanne Schow as Senior Vice President, Business Development. Jeanne will be based out of the San Francisco Bay Area. Meet Jeanne Schow and the Avance Clinical North American team at the next biotech event. Book a Meeting Here. Yvonne Lungershausen, CEO of Avance Clinical, expressed her enthusiasm about Jeanne’s appointment, highlighting the significant expertise she brings to the team. “We are extremely pleased to have Jeanne Schow…

NEW YORK, July 31, 2024 (GLOBE NEWSWIRE) — Today, Fiverr, the company changing how the world works together, announced its acquisition of AutoDS, which provides a subscription-based end-to-end solution for dropshippers, including product research and sourcing, inventory management, and automated fulfillment. With its expansive global reach and an omni-channel approach, it aggregates over 150 million products and serves tens of thousands of paying subscribers on its platform. “AutoDS has built an impressive product and community that is highly synergetic with Fiverr. Dropshipping and its adjacent services in marketing and programming verticals are some of the fastest growing categories on Fiverr.…

HSINCHU and TAINAN, Taiwan, July 31, 2024 (GLOBE NEWSWIRE) — E Ink Holdings Inc. (8069.TWO) (“E Ink”), an originator, pioneer and commercial leader in ePaper technology and Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced the joint debut of next generation color ePaper timing controller ASIC (“TCON”), the T2000. The new TCON design drives screen updates at a faster speed with lower power consumption, supporting a broad spectrum of color ePaper technology platforms aimed at eReaders, digital signages, and other ePaper platforms. The T2000 eNote handwriting function…

SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) — Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired MacroGenics, Inc. (NASDAQ: MGNX) common stock between March 7, 2024 and May 9, 2024. MacroGenics is a biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that MacroGenics, Inc. (MGNX) Misled Investors Regarding the Viability…